| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.085 | 0.07 |